Long-term outcome after primary angioplasty: report from the primary angioplasty in myocardial infarction (PAMI-I) trial (Q33542019)

27 July 2017

title

Long-term outcome after primary angioplasty: report from the primary angioplasty in myocardial infarction (PAMI-I) trial (English)

1 reference

27 July 2017

main subject

myocardial infarction

1 reference

1 reference

Nunn CM

1

1 reference

27 July 2017

O'Neill WW

2

1 reference

27 July 2017

Rothbaum D

3

1 reference

27 July 2017

Stone GW

4

1 reference

27 July 2017

O'Keefe J

5

1 reference

27 July 2017

Overlie P

6

1 reference

27 July 2017

Donohue B

7

1 reference

27 July 2017

Grines L

8

1 reference

27 July 2017

Browne KF

9

1 reference

27 July 2017

Vlietstra RE

10

1 reference

27 July 2017

Catlin T

11

1 reference

27 July 2017

Grines CL

12

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

Journal of the American College of Cardiology

27 July 2017

published in

1 reference

27 July 2017

volume

33

1 reference

27 July 2017

issue

3

1 reference

27 July 2017

page(s)

640-646

1 reference

Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900622-6

7 January 2021

Percutaneous transluminal coronary angioplasty in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900622-6

7 January 2021

Percutaneous transluminal coronary angioplasty in evolving acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900622-6

7 January 2021

A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900622-6

7 January 2021

Early and late results of coronary angioplasty without antecedent thrombolytic therapy for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900622-6

7 January 2021

Direct coronary angioplasty in acute myocardial infarction: outcome in patients with single vessel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900622-6

7 January 2021

Catheterization laboratory events and hospital outcome with direct angioplasty for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900622-6

7 January 2021

Results of primary angioplasty for acute myocardial infarction in patients with multivessel coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900622-6

7 January 2021

A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900622-6

7 January 2021

A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900622-6

7 January 2021

Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900622-6

7 January 2021

Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900622-6

7 January 2021

A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900622-6

7 January 2021

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900622-6

7 January 2021

Angiographic findings and catheterization laboratory events in patients with primary coronary angioplasty or streptokinase therapy for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900622-6

7 January 2021

One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900622-6

7 January 2021

A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900622-6

7 January 2021

A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. Myocardial Infarction Triage and Intervention Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900622-6

7 January 2021

The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900622-6

7 January 2021

Does thrombolysis in myocardial infarction (TIMI) perfusion grade 2 represent a mostly patent artery or a mostly occluded artery? Enzymatic and electrocardiographic evidence from the TEAM-2 study. Second Multicenter Thrombolysis Trial of Eminase in

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900622-6

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900622-6

7 January 2021

Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900622-6

7 January 2021

Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial. Primary Angioplasty in Myocardial Infarction Stent Pilot Trial Investigato

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900622-6

7 January 2021

10.1016/S0735-1097(98)00622-6

Identifiers

DOI

1 reference

27 July 2017

1 reference